TRACER PHARMA ApS: Financial statements 2017
CVR: 34090106
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,509,298 and a net result of DKK 20,350 compared with DKK 123,002 the year before. That is a decrease of 19.2% compared with the year before. Equity in the 2017 report amounted to DKK 227,439. The solvency ratio was 6.4%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,509,298
- Profit/Loss
- DKK 20,350
- Equity
- DKK 227,439
- Total Assets
- DKK 3,526,749
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.5 mio. | 20 t. | 227 t. | 4 |
| 2016 | - | 3.1 mio. | 123 t. | 207 t. | - |
| 2015 | - | 2.2 mio. | 30 t. | 114 t. | - |
| 2014 | - | 2 mio. | 123 t. | 204 t. | - |
Official annual report
Keep an eye on TRACER PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.